Blog
RSS FeedPosted by Michael Wonder on 22 Nov 2019
Speaker Pelosi’s drug pricing plan could result in 56 fewer new medicines over 10 years
21 November 2019 - International reference pricing provisions in plan would decimate development of innovative medicines by nearly 90%. ...
Posted by Michael Wonder on 21 Nov 2019
Drug for ultra rare disease comes with ultra high price tag
21 November 2019 - Givlaari’s net price will be $442,000 after discounts included. ...
Posted by Michael Wonder on 21 Nov 2019
Doctors who helped develop heart drug now balk at $225,000/year price
19 November 2019 - Wearing a revolutionary-era tricorn hat, doctor Mathew Maurer stood at a lectern in front of an ...
Posted by Michael Wonder on 19 Nov 2019
In a rare political move, prominent biotech venture capitalists speak out against Pelosi’s drug pricing bill
18 November 2019 - A group of top biotech venture capitalists are issuing a stark warning to Congress: They won’t ...
Posted by Michael Wonder on 18 Nov 2019
National MS Society responds to price of new Biogen/Alkermes MS medication Vumerity
13 November 2019 - The FDA recently approved a new medication for relapsing MS, Vumerity, by Biogen and Alkermes. ...
Posted by Michael Wonder on 14 Nov 2019
To drive down insulin prices, WHO will certify generic versions
13 November 2019 - About 80 million people with diabetes around the world need the hormone, and half of them can’t ...
Posted by Michael Wonder on 06 Nov 2019
One shot drug to end Sicilian curse comes at $1.8 million cost
5 November 2019 - A new targeted gene therapy shows the promise and pitfalls of medical advances. ...
Posted by Michael Wonder on 25 Oct 2019
Amgen to make Repatha (evolocumab) available exclusively at its lower list price option in 2020
24 October 2019 - Repatha original list price option will be discontinued effective 31 December 2019. ...
Posted by Michael Wonder on 23 Oct 2019
Vertex prices cystic fibrosis combo treatment at $311,000-per-year
22 October 2019 - Vertex Pharmaceuticals has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning ...
Posted by Michael Wonder on 17 Oct 2019
Pelosi’s drug pricing plan puts medical innovation at risk
17 October 2019 - The future of medical innovation in America is at a crossroads. ...
Posted by Michael Wonder on 11 Oct 2019
MSF demands Johnson & Johnson reduce price of life saving TB drug
11 October 2019 - Pharma company Johnson and Johnson sell TB drug bedaquiline for nearly US$1,200 per treatment course, a price ...
Posted by Michael Wonder on 11 Oct 2019
Pharma industry is 'right in the crosshairs,' Merck CEO Kenneth Frazier says
11 October 2019 - President Donald Trump and House Speaker Nancy Pelosi are in a battle over impeachment but their ...
Posted by Michael Wonder on 02 Oct 2019
The real impact of drug price legislation on biopharmaceutical R&D
2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...
Posted by Michael Wonder on 02 Oct 2019
Trade agreement drug monopoly is obsolete given faster, better drug discovery
2 October 2019 - For decades, the brand-name drug industry has relentlessly promoted the message that any reduction in its ...
Posted by Michael Wonder on 23 Sep 2019
Novo prices oral Rybelsus on par with injectable rivals, ending discount fears
23 September 2019 - Monday morning, Bernstein analyst Wimal Kapadia echoed what many industry watchers were probably thinking about Novo ...